Rymarz Zdort Maruta's team garners praise for its 'deep and comprehensive understanding of the healthcare market'. The group boasts extensive expertise in advising on cases in the medical devices and pharmaceutical sectors, with a solid track record in assisting with regulatory issues, reimbursement, advertising, financing and clinical trials. Michał Czarnuch is sought after for his experience in handling distribution matters, while Tomasz Kaczynski acts on transactional cases; the duo co-head the practice with Marcin Pieklak. Pawel Kazmierczyk is a key contact.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- The team demonstrates a deep and comprehensive understanding of the healthcare market. Their knowledge extends beyond surface-level trends, covering regulatory frameworks, patient needs, provider challenges, and emerging technologies shaping the sector. This expertise allows them to identify opportunities, anticipate changes, and develop strategies that align with both market demands and compliance standards. Their informed perspective adds significant value to any project or collaboration within the healthcare domain.
- The individuals I work with demonstrate a high level of expertise, strong responsiveness, and genuine commitment. Their deep knowledge and professionalism are evident in every stage of the project, while their ability to react quickly and effectively ensures smooth collaboration. They consistently show dedication to achieving the best outcomes and maintaining high standards of quality.
- ‘The Healthcare and Life Sciences team at Rymarz Zdort Maruta is a pleasure to work with. They’re knowledgeable, responsive, and really understand the regulatory landscape. What I appreciate most is their practical approach and ability to find solutions quickly.'
- ‘The team at Rymarz Zdort Maruta is excellent, and what really makes them stand out is how easy they are to work with. They’re knowledgeable, responsive, and always focused on finding practical solutions. Tomasz Kaczyński is sharp, reliable, and brings a lot of clarity to complex issues.'
- 'Highly professional, proactive, supportive and quick.’
- ‘Michal is fantastic, he is practical, responsive, and always focused on solutions. He takes the time to really understand our business and the unique challenges of operating in the health tech space, which makes his advice both commercially savvy and actionable. His ability to balance legal rigour with a clear understanding of our goals has been invaluable.’
Key clients
- Celon Pharma S.A.
- Asseco Poland S.A.
- Hitachi Europe Ltd.
- Stallergenes Polska sp. z o.o.
- Exeltis Poland Sp. z o.o. – Aristo Case
- American Heart of Poland (Grupa AHP)
- Hemolens Diagnostics Sp. z o.o.
- Bausch + Lomb
- ZnanyLekarz Sp. z o.o.
- Eli Lilly Poland Sp. z o.o.
- Takeda Pharmaceutical Company Limited
- MagnaPharm Poland sp. z o. o.
- Polska Dystrybucja Farmaceutyczna (PLDF)
- Zdrowit
Work highlights
Advised Exeltis Poland Sp. z o.o. on the acquisition of rights to the medicinal product Axyven from Aristo Pharma.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
Michał Czarnuch; Tomasz Kaczynski; Marcin Pieklak
Other key lawyers
Pawel Kazmierczyk